Swaminathan Padmanabhan Iyer

Professor

  • 3619 Citations
  • 29 h-Index
20032019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2003 2019

  • 3619 Citations
  • 29 h-Index
  • 68 Article
  • 11 Letter
  • 8 Review article
  • 2 Comment/debate
Filter
Comment/debate
2014

Erratum: WTAP is a novel oncogenic protein in acute myeloid leukemia (Leukemia (2014) 28 (1171-1174) DOI: 10.1038/leu.2014.16)

Bansal, H., Yihua, Q., Iyer, S. P., Ganapathy, S., Proia, D. A., Penalva, L. O., Uren, P. J., Suresh, U., Carew, J. S., Karnad, A. B., Weitman, S., Tomlinson, G. E., Rao, M. K., Kornblau, S. M. & Bansal, S., Dec 11 2014, In : Leukemia. 28, 12, 1 p.

Research output: Contribution to journalComment/debate

Core Binding Factor alpha Subunits
Leukemia
2010

Erratum: Ofatumumab, a novel CD20 monoclonal antibody, is active in patients with fludarabine- and alemtuzumab-refractory or bulky fludarabine-refractory chronic lymphocytic leukemia irrespective of prior rituximab (Clinical lymphoma & Myeloma (2009) 9: 6 (E36) DOI: 10.3816/CLM.2009.n.098)

Wierda, W. G., Kipps, T., Mayer, J., Stilgenbauer, S., Williams, C. D., Hellmann, A., Robak, T., Furman, R. R., Hillmen, P., Trneny, M., Dyer, M. J. S., Iyer, S. P., Piotrowska, M., Kozak, T., Chan, G., Davis, R., Losic, N., Wilms, J., Russell, C. & Österborg, A., Jan 1 2010, In : Clinical Lymphoma, Myeloma and Leukemia. 10, 2, 1 p.

Research output: Contribution to journalComment/debate

B-Cell Chronic Lymphocytic Leukemia
Lymphoma
Monoclonal Antibodies
Rituximab
alemtuzumab